SEngine Precision Medicine

SEngine Precision Medicine

SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine`s high-throughput technology simultaneously tests more than 200 cancer drugs against a patient`s unique tumor organoid outside the body. The results decode the most effective and least toxic treatment options that DNA sequencing alone cannot reveal. The proprietary platform leverages the aggregated, anonymized test results to develop new cancer-fighting drugs.

Company details

401 Terry Ave N.,Seattle,98109

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Nationally (across the country)

Contact supplier

Drop file here or browse